Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Possible New Standard for Treated Advanced CRC With KRAS Mutations

SAN DIEGO — A third of patients with previously treated unresectable/metastatic KRASG12C-mutated colorectal cancer (CRC) responded to a combination of targeted drugs, a preliminary prospective

April 13, 2024

Robert F. Kennedy is pitching centrism on health care, even on abortion

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays. What RFK’s new lane means

October 10, 2023

Bausch Health’s Salix initiates first awareness day for opioid-induced constipation

Salix Pharmaceuticals is partnering with two advocacy groups to establish a first-ever opioid-induced constipation (OIC) awareness day to help dispel the stigma and silence around

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.